APA (7th ed.) Citation

MJ, J., SS, K., A, B., C, H., M, J., A, W., . . . V, J. (2022). Angiotensin receptor blockers for the treatment of covid-19: Pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ (Clinical research ed.), 379, e072175. https://doi.org/10.1136/bmj-2022-072175

Chicago Style (17th ed.) Citation

MJ, Jardine, et al. "Angiotensin Receptor Blockers for the Treatment of Covid-19: Pragmatic, Adaptive, Multicentre, Phase 3, Randomised Controlled Trial." BMJ (Clinical Research Ed.) 379 (2022): e072175. https://doi.org/10.1136/bmj-2022-072175.

MLA (9th ed.) Citation

MJ, Jardine, et al. "Angiotensin Receptor Blockers for the Treatment of Covid-19: Pragmatic, Adaptive, Multicentre, Phase 3, Randomised Controlled Trial." BMJ (Clinical Research Ed.), vol. 379, 2022, p. e072175, https://doi.org/10.1136/bmj-2022-072175.